ArticleMolecular cancer2018

Posttranscriptional upregulation of HER3 by HER2 mRNA induces trastuzumab resistance in breast cancer.

Xin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.